Alopecia Market - Forecast(2024 - 2030)

Report Code: HCR 1308 Report Format: PDF + Excel

Alopecia Market Overview

The global Alopecia Market is estimated to grow at a CAGR of 8.15% during the forecast period 2019–2025. The market is projected to grow from $2.63bn in 2018 to $4.54bn by 2025. Alopecia is medical condition that leads to hair loss and baldness eventually. Hair loss may happen in patches or whole from a small area to the entire body. Alopecia is caused due to autoimmune disorders such as thyroid, vitiligo and others. Asthma, allergies and others may also be another cause of alopecia. The report covers Alopecia Market size by type and applications, Alopecia Market share by top 5 companies and also the market share by start-ups during the forecast period.

Key Takeaways

  • In the coming years, growing prevalence of the condition is set to drive the growth of the market.
  • Product launches were the key sustainability strategy adopted by the market players to ensure the growth of Alopecia Market.
  • APAC region is estimated to record the fastest growth rate during the forecast period.

Disease Type - Segment Analysis

In 2018, Alopecia areata segment dominated the Alopecia Market in terms of revenue. It is forecast to grow at a CAGR of 6.71% during the period under consideration.  Alopecia areata is a case when hair loss occurs in circular patches. This happens as a result of body’s immune system attacking healthy its own hair follicles.

Treatment Type - Segment Analysis

In 2018, Topical agents segment dominated the Alopecia Market in terms of revenue. Topical agents are creams or lotions applied in the affected area. People prefer topical agents as they are a safer option and leads to less side effects and contains enhanced ingredients.

Gender - Segment Analysis

Alopecia was more prominent issue among men. Hence the Male segment dominated the Alopecia Market in 2018. Alopecia is also growing among females and is mainly attributed to Polycystic Ovary Syndrome (PCOS), a hormonal disorder resulting in enlarged ovaries and causes psychological distress to women.

Distribution Channel - Segment Analysis

Pharmacies segment dominated the Alopecia Market in 2018. This can be mainly attributed to the growth of OTC medicines available in the market. Hospitals/Clinics are fast growing segments and is expected to dominate the market in future.

Geography - Segment Analysis

In 2018, the North America region occupied 42% of the global Alopecia Market in terms of revenue. National Alopecia Areata recorded that in the U.S., approximately 6.8 million individuals had been diagnosed till 2017. APAC region is estimated to record the fastest growth rate during the forecast period.

Drivers – Alopecia Market

Growing patient awareness

Alopecia’s symptoms are usually very visible and is easy to identify. Individuals with the condition are seeking medical assistance as it affects their self-esteem and self-confidence. These psychological traits have forced people to become aware of the condition and find adequate cure. 

Challenges – Alopecia Market

  • No Full Cure for Alopecia

The individuals are made aware of the fact that there is no full cure for the condition and the only medication is for increasing the pace at which hair grows.

  • People Giving Up on Medication

Lately, individuals with the condition are accepting and embracing the fact that their hair will never grow again and this portion of the population avoids the need of medications for alopecia.

 Alopecia industry outlook

Product Launches along with mergers were the key strategies of the players in the alopecia Industry. Alopecia top 10 companies include Vita-Cos-Med Klett-Loch GmbH, Transitions Hair Pty Ltd, Sun Pharmaceutical Industries Ltd, Merck & Co.Inc, Lexington International LLC, Johnson and Johnson AG, Follica Inc, Cirrus Hair Centers, Cipla Inc, Capillus.

Alopecia Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Alopecia Market. The assessment includes the forecast, an overview of the competitive structure, the Alopecia Market share of the competitors, as well as the Alopecia Market size market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This Alopecia Market report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include disease type, treatment type, gender, distribution channels, and geographic analysis. 

1. Alopecia Market Overview
2. Alopecia Market Executive Summary
3. Alopecia Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. End User Profiling
3.2.2. Patent Analysis
4. Alopecia Market Forces
4.1. Market Drivers
4.2. Market Constraints & Challenges
5. Alopecia Market Strategic Analysis
5.1. Value Chain Analysis
5.2. Opportunities Analysis
5.3. Product/Market Lifecycle Analysis
6. Alopecia Market - By Type
6.1. Introduction
6.2. Alopecia Areata
6.3. Traction Alopecia
6.4. Androgenic Alopecia
6.5. Ciatricial Alopecia
6.6. Alopecia Totalis
7. Alopecia Market - By Treatment Type
7.1. Introduction
7.2. Topical Minoxidil
7.3. Anthralin Cream Or Ointment
7.4. Topical Corticosteroids
7.5. Topical Immunotherapy
7.6. Oral Corticosteroids
7.7. 5-Alpha Reductase Inhibitors
7.8. Immunosuppressant
7.9. Others
8. Alopecia Market - By Gender Type
8.1. Introduction
8.2. Male 
8.3. Female
9. Alopecia Market - By Geography
9.1. Americas
9.1.1. North America U.S. Canada Mexico
9.1.2. South America Brazil Argentina Chile Rest of South America
9.2. Europe
9.2.1. U.K.
9.2.2. France
9.2.3. Russia
9.2.4. Germany
9.2.5. Italy
9.2.6. Spain
9.2.7. Rest of Europe
9.3. Asia-Pacific (APAC)
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Australia & New Zealand
9.3.5. South Korea
9.3.6. Rest of APAC
9.4. RoW
9.4.1. Middle East
9.4.2. Africa
10. Alopecia Market Entropy
11. Alopecia Market Company Profiles
11.1. Company 1
11.2. Company 2
11.3. Company 3
11.4. Company 4
11.5. Company 5
11.6. Company 6
11.7. Company 7
11.8. Company 8
11.9. Company 9
11.10. Company 10 and more
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer